223
Views
22
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Efficacy and Safety of Indacaterol, a New 24-hour β2-Agonist, in Patients with Asthma: A Dose-Ranging Study

, , , , &
Pages 887-892 | Published online: 02 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Ernesto Crisafulli, Annalisa Frizzelli, Alberto Fantin, Alessandra Manco, Angelo Mangia, Giovanna Pisi, Valentina Fainardi, Veronica Alfieri, Marina Aiello, Giuseppina Bertorelli & Alfredo Chetta. (2017) Next generation beta adrenoreceptor agonists for the treatment of asthma. Expert Opinion on Pharmacotherapy 18:14, pages 1499-1505.
Read now
Santiago Quirce, Irina Bobolea & Pilar Barranco. (2012) Emerging drugs for asthma. Expert Opinion on Emerging Drugs 17:2, pages 219-237.
Read now
Christopher KM Hui & Kian F Chung. (2011) Indacaterol: pharmacologic profile, efficacy and safety in the treatment of adults with COPD. Expert Review of Respiratory Medicine 5:1, pages 9-16.
Read now
Craig LaForce, Phillip Korenblat, Pamela Osborne, Fang Dong & Mark Higgins. (2009) 24-hour bronchodilator efficacy of single doses of indacaterol in patients with persistent asthma: comparison with placebo and formoterol. Current Medical Research and Opinion 25:10, pages 2353-2359.
Read now

Articles from other publishers (18)

Luigino Calzetta, Marina Aiello, Annalisa Frizzelli, Elena Pistocchini, Beatrice Ludovica Ritondo, Paola Rogliani & Alfredo Chetta. (2022) Investigational Treatments in Phase I and II Clinical Trials: A Systematic Review in Asthma. Biomedicines 10:9, pages 2330.
Crossref
David Miller, Soniya Vaidya, Juergen Jauernig, Brian Ethell, Kristina Wagner, Rajkumar Radhakrishnan & Hanns-Christian Tillmann. (2020) Lung function, pharmacokinetics, and tolerability of inhaled indacaterol maleate and acetate in asthma patients. Respiratory Research 21:1.
Crossref
Ritesh Agarwal, Sahajal Dhooria, AshutoshNath Aggarwal, VenkataN Maturu, InderpaulS Sehgal, Valliappan Muthu, KuruswamyT Prasad, LakshmikantB Yenge, Navneet Singh, Digambar Behera, SurinderK Jindal, Dheeraj Gupta, Thanagakunam Balamugesh, Ashish Bhalla, Dhruva Chaudhry, SunilK Chhabra, Ramesh Chokhani, Vishal Chopra, DevendraS Dadhwal, George D′Souza, Mandeep Garg, ShailendraN Gaur, Bharat Gopal, AlokeG Ghoshal, Randeep Guleria, KrishnaB Gupta, Indranil Haldar, Sanjay Jain, NirmalK Jain, VikramK Jain, AshokK Janmeja, Surya Kant, Surender Kashyap, GopiC Khilnani, Jai Kishan, Raj Kumar, ParvaizA Koul, Ashok Mahashur, AmitK Mandal, Samir Malhotra, Sabir Mohammed, PrasantaR Mohapatra, Dharmesh Patel, Rajendra Prasad, Pallab Ray, JaiK Samaria, PotsangbamSarat Singh, Honey Sawhney, Nusrat Shafiq, Navneet Sharma, Updesh PalS Sidhu, Rupak Singla, JagdishC Suri, Deepak Talwar & Subhash Varma. (2015) Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations. Lung India 32:7, pages 3.
Crossref
Lorraine Murphy, Stephen Rennard, James Donohue, Mathieu Molimard, Ronald Dahl, Kai-Michael Beeh, Juergen Dederichs, Hans-Jürgen Fülle, Mark Higgins & David Young. (2014) Turning a Molecule into a Medicine: the Development of Indacaterol as a Novel Once-Daily Bronchodilator Treatment for Patients with COPD. Drugs 74:14, pages 1635-1657.
Crossref
Jutta Beier & Kai M. Beeh. 2014. Indacaterol. Indacaterol 67 76 .
Mario Cazzola, Clive P. Page, Luigino Calzetta & M. Gabriella Matera. (2012) Pharmacology and Therapeutics of Bronchodilators. Pharmacological Reviews 64:3, pages 450-504.
Crossref
Shaunta' M. Ray, James C. McMillen, Sarah A. Treadway, Robert S. Helmer & Andrea S. Franks. (2012) Indacaterol: A Novel Long‐Acting β 2 ‐Agonist . Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 32:5, pages 456-474.
Crossref
Mario Cazzola & Maria Gabriella Matera. 2012. Advances in Combination Therapy for Asthma and COPD. Advances in Combination Therapy for Asthma and COPD 81 101 .
Peter J BarnesMario CazzolaMaria Gabriella Matera. 2012. Addressing Unmet Medical Needs in COPD Management. Addressing Unmet Medical Needs in COPD Management 64 75 .
Mario Cazzola, Luigino Calzetta & Maria Gabriella Matera. (2011) β2-adrenoceptor agonists: current and future direction. British Journal of Pharmacology 163:1, pages 4-17.
Crossref
Federico L Dente, Elena Bacci, Barbara Vagaggini & Pierluigi Paggiaro. (2011) Role of indacaterol in the management of asthma and chronic obstructive pulmonary disease. Clinical Investigation 1:4, pages 589-602.
Crossref
Naruhiko Sugihara, Shigeto Kanada, Michiko Haida, Masakazu Ichinose, Mitsuru Adachi, Motoi Hosoe, Charlotte Emery, Mark Higgins & Benjamin Kramer. (2010) 24-h bronchodilator efficacy of single doses of indacaterol in Japanese patients with asthma: A comparison with placebo and salmeterol. Respiratory Medicine 104:11, pages 1629-1637.
Crossref
François Baur, David Beattie, David Beer, David Bentley, Michelle Bradley, Ian Bruce, Steven J. Charlton, Bernard Cuenoud, Roland Ernst, Robin A. Fairhurst, Bernard Faller, David Farr, Thomas Keller, John R. Fozard, Joe Fullerton, Sheila Garman, Julia Hatto, Claire Hayden, Handan He, Colin Howes, Diana Janus, Zhengjin Jiang, Christine Lewis, Frederique Loeuillet-Ritzler, Heinz Moser, John Reilly, Alan Steward, David Sykes, Lauren Tedaldi, Alexandre Trifilieff, Morris Tweed, Simon Watson, Elke Wissler & Daniel Wyss. (2010) The Identification of Indacaterol as an Ultralong-Acting Inhaled β 2 -Adrenoceptor Agonist . Journal of Medicinal Chemistry 53:9, pages 3675-3684.
Crossref
. (2010) Current World Literature. Current Opinion in Pulmonary Medicine 16:1, pages 77-82.
Crossref
Mario Cazzola, Andrea Segreti & Maria G Matera. (2010) Novel bronchodilators in asthma. Current Opinion in Pulmonary Medicine 16:1, pages 6-12.
Crossref
Kai M. Beeh & Jutta Beier. (2009) Indacaterol, a novel inhaled, once-daily, long-acting beta2-agonist for the treatment of obstructive airways diseases. Advances in Therapy 26:7, pages 691-699.
Crossref
L.-P. Boulet. (2009) Le traitement pharmacologique de l’asthme : regard sur le futur. Revue des Maladies Respiratoires Actualités 1, pages S83-S85.
Crossref
. (2009) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 18:5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.